Drug Patent Watch

AUGUST 8, 2023

A recent study explores the landscape of authorized generics in the United States pharmaceutical market. Authorized generics are brand-name drugs that are marketed without their original branding.

Marketing 96

Marketing Pharmaceuticals Drugs 96

Drug Patent Watch

DECEMBER 10, 2024

In this article, we will delve into the benefits of working with integrated CDMO services and explore how they can streamline the drug development and manufacturing process. The Rise of Integrated CDMOs The global biotechnology and pharmaceutical services outsourcing market size was valued at $70.48 from 2023 to 2030.

Drug Development 96

Drug Development Compliance Pharmaceutical Companies Drugs 96

Drug Patent Watch

DECEMBER 8, 2024

The pharmaceutical industry is heavily reliant on patents to protect intellectual property and maintain market exclusivity. In this article, we will delve into the strategies and considerations for handling drug patent… Source

Biosimilars 98

Biosimilars Pharmaceutical Companies Drugs Pharmaceuticals 98

Perficient: Drug Development

SEPTEMBER 17, 2024

This year, I’m particularly excited about how far we’ve advanced with Optimizely One in collaboration with Perficient, which is described as an operating system for marketing teams. Many organizations are shifting away from piecing together various products to build their marketing technology systems. Will you be at Opticon 2024?

Marketing 109

Marketing Production Government 109

Drug Patent Watch

FEBRUARY 11, 2025

Behind the scenes, companies are employing clever tactics to protect their intellectual property and block competitors from entering the market. From strategic patent filings to aggressive litigation, these companies will stop at nothing to maintain their market dominance. Read the full article here But at what cost?

Drugs 96

Drugs Treatment Marketing Production 96

Drug Patent Watch

DECEMBER 10, 2024

This article delves into India’s growing importance in generic drug API manufacturing, highlighting the key factors contributing to its success and the challenges it faces. The “Ayushman Bharat Yojana” scheme, which aims to provide affordable healthcare to citizens, has further boosted the domestic market’s prospects.

Government 97

Government Drugs Pharmacy Pharmaceuticals 97

Drug Patent Watch

DECEMBER 11, 2024

This article outlines key considerations and strategies for developing a sustainable generic drug development strategy. Addressing Competition and Market Dynamics The lack of competition in the generic drug market contributes to price hikes and shortages. “Generics are known for their cost-effectiveness.

Drug Development 98

Drug Development Compliance Drugs Pharmaceuticals 98

Drug Patent Watch

MARCH 16, 2025

In this article, we'll explore the impact of biosimilars on biologic drug life cycle management. From patent challenges to market competition, we'll dive into the ways in which biosimilars are changing the game for biologic drug manufacturers. But biosimilars aren't just about patent challenges they're also about market competition.

Biosimilars 52

Biosimilars Drugs Marketing Pharmaceuticals 52

Drug Patent Watch

FEBRUARY 12, 2025

However, delays in any of these stages can significantly impact the overall timeline, leading to missed market opportunities and revenue losses. By implementing these strategies, generic drug manufacturers can accelerate their development timelines, improve efficiency, and increase their chances of success in the market.

Drug Development 81

Drug Development Drugs Compliance Regulations 81

Drug Patent Watch

JANUARY 21, 2025

As more and more biosimilars come to market, we can expect to see a significant reduction in the cost of biologics. Read the full article here: [link] This is a win-win for everyone involved patients get the treatments they need, and healthcare systems can allocate resources more efficiently. Share your thoughts in the comments below!

Biosimilars 95

Biosimilars Government Treatment Pharmaceuticals 95

Drug Patent Watch

MARCH 22, 2022

FEATURED ARTICLE Branded Generics Promise Profits for Drugmakers, Peace of Mind for Patients Developing nations offer welcoming and growing markets as Abbott focuses exclusively on reformulating and marketing off-patent medications….

Marketing 120

Marketing 120

Drug Patent Watch

DECEMBER 30, 2024

This article aims to provide a comprehensive overview of the key aspects of the regulatory framework, highlighting the requirements and challenges faced by pharmaceutical companies seeking to introduce generic drugs into the Japanese market. New Drug Application (NDA) : Needed for marketing approval of new drugs.

Drug Development 52

Drug Development Clinical Pharmacology Clinical Trials Pharmaceutical Companies 52

Drug Patent Watch

JUNE 17, 2024

The article “The devil is in the divisional: an analysis of divisional patents, deadlines, declarations and suggestions for future practice” by Mieke Filler provides a comprehensive analysis of the strategic use of divisional patents in the pharmaceutical sector to delay generic and biosimilar market entry.

Biosimilars 110

Biosimilars Pharmaceuticals Marketing 110

Perficient: Drug Development

SEPTEMBER 26, 2023

If there’s one thing healthcare marketers need more of, it’s time. Your day is most likely taken up with monitoring campaigns, analyzing metrics of your digital marketing, adjusting strategies and, of course, meetings. You do want to provide context for the topics you discuss in articles. But you don’t want to be too clinical.

Marketing 52

Marketing Engineering Doctors Research 52

FDA Law Blog: Biosimilars

OCTOBER 16, 2023

Gonzalez — The Wall Street Journal (WSJ) recently published a series of articles as part of its special report “What’s Ahead for Artificial Intelligence.” Three of these articles focus on medical applications of Artificial Intelligence and Machine Learning (AI/ML) and explore FDA’s role in regulating such products.

Regulations 119

Regulations FDA Production Disease 119

Drug Patent Watch

JUNE 27, 2024

Introduction Patent portfolios are critical assets for pharmaceutical companies, providing market exclusivity and protecting revenue streams for drug products. This article explores key best practices for optimizing drug patent portfolios to maximize value and maintain competitive advantage. […] Source

Pharmaceutical Companies 105

Pharmaceutical Companies Drugs Pharmaceuticals Production 105

Perficient: Drug Development

OCTOBER 18, 2023

In the fast-paced world of digital marketing, staying ahead of the curve is crucial for success. We highly recommend giving this article a thorough read. It’s not just a guide—it’s a roadmap to unlocking the full potential of personalization in your digital marketing endeavors.

Marketing 52

Marketing 52

Agency IQ

SEPTEMBER 29, 2023

The intent is to create a single market for data, establish common European data spaces, and allow the companies that generate the data to keep control and maintain trade secrets. Fill out the form to read the full article.

Marketing 59

Marketing 59

Agency IQ

SEPTEMBER 22, 2023

It appears the issue is largely the result of unclear labeling for biocidal disinfectants, an aspect French regulators may flag in future market authorization evaluations for these products. Fill out the form to read the full article. Group 1 for disinfectants contains five product-types.

Regulations 59

Regulations Production Marketing 59

Perficient: Drug Development

MARCH 5, 2024

Depending on the size of your marketing team, one high-quality blog article a week could be a big ask. We’ve pulled together seven strategies for how to stock your editorial calendar with the kinds of relevant article topics your healthcare organization’s consumers are asking for.

Marketing 52

Marketing Research 52

Drug Patent Watch

JANUARY 21, 2025

Identify and Prioritize Patent Opportunities With so many patent applications flooding the market, it's easy to get overwhelmed. By analyzing patent trends, competitor activity, and market demand, you can gain a deeper understanding of the patent landscape and make more informed decisions. Read the full article here: [link]

Drugs 59

Drugs Pharmaceutical Companies Pharmaceuticals Marketing 59

Drug Patent Watch

DECEMBER 10, 2024

” These dense webs of overlapping patent rights can significantly impact innovation, market entry, and competition across various industries and countries. In this comprehensive article, we’ll explore how patent thickets vary across different countries and their implications for businesses, inventors, and policymakers worldwide.

Licensing 98

Licensing Licensing International Marketing 98

ACTO

NOVEMBER 13, 2023

By Alison Muller Chief Marketing Officer ACTO PM360 asked data experts what hidden insights companies may already have if they just know how to look for it as well as the best way to get buy-in on predictive analytics or next best action recommendations. Read the full article here. Email Alison at alison@actoapp.com.

Pharmaceutical Companies 52

Pharmaceutical Companies Marketing Production Pharmaceuticals 52

Perficient: Drug Development

DECEMBER 12, 2024

Social media is a pivotal component of any marketing strategy in today’s digital era. Salesforce Marketing Cloud Social Studio offers a comprehensive platform for managing, scheduling, creating, and monitoring social media posts. What is Salesforce Marketing Cloud Social Studio?

Marketing 52

Marketing 52

Perficient: Drug Development

SEPTEMBER 3, 2024

The world of Digital Marketing is challenging and always updating with new strategies. Gen AI can pump up your digital marketing efforts by creating highly engaged SEO-friendly content and boost your brand on SERP (Search Engine Result Page). What is Generative AI, and How Does it Work?

Marketing 52

Marketing Production Engineering Research 52

Drug Patent Watch

DECEMBER 17, 2024

Contract Development and Manufacturing Organizations (CDMOs) are at the forefront of this shift, playing a crucial role in bringing innovative therapies to market. Responding to Market Demands The pharmaceutical market is notoriously unpredictable. Flexibility has become more than just a buzzword it’s a necessity.

Pharmaceuticals 90

Pharmaceuticals Therapies Production Pharmaceutical Companies 90

Perficient: Drug Development

OCTOBER 8, 2024

One shining example is our recruitment strategy for Bayhealth, which was recently featured by the online publication, Strategic Health Care Marketing. Recognizing the need for a unified front, our team emphasized the importance of collaboration between HR and marketing.

Marketing 52

Marketing Testimonials Hospitals Science 52

Perficient: Drug Development

NOVEMBER 13, 2023

What You’ll Learn from the Piece This article discusses the concept of unified commerce and how it goes beyond omnichannel retail by connecting and synchronizing all channels, systems, and processes, both front-end and back-end, to deliver a consistent shopping experience.

Marketing 52

Marketing 52

Agency IQ

JANUARY 4, 2024

Fill out the form to read the full article. The Swiss regulator, Swissmedic, just announced a reorganization, with a new head of the medicinal product authorization and vigilance sector, but also a new and discrete medical devices surveillance sector. AgencyIQ takes a look at what this could mean for medical device manufacturers.

Marketing 59

Marketing Regulations Production 59

Chemical Biology and Drug Design

MARCH 14, 2025

Surface plasmon resonance screening of fragments and marketed drugs revealed extensive binding to the empty ND, correlating with analyte hydrophobicity, and the binding was critically dependent on ND lipid composition.

Fragment Screening 100

Fragment Screening Pharmacokinetics Drugs Marketing 100

Drug Patent Watch

FEBRUARY 26, 2025

In this article, we'll delve into the world of drafting drug patent applications for biologic drugs. Regulatory compliance : Biologics are subject to strict regulatory requirements, including those related to manufacturing, labeling, and marketing. Read the full article here: [link]

Drugs 59

Drugs Government Regulations Compliance 59

Drug Patent Watch

JULY 27, 2023

Here’s a summary of a new article that used DrugPatentWatch data: NIH Funding for Patents That Contribute to Market Exclusivity of Drugs Approved 2010–2019 and the Public Interest Protections of… The post DrugPatentWatch reveals NIH funding for patents appeared first on DrugPatentWatch - Make Better Decisions.

Marketing 97

Marketing Drugs 97

Drug Patent Watch

FEBRUARY 3, 2021

This article was originally published by Ioana Gherghescu and Begoña Delgado-Charro in Pharmaceutics 2021, 13(1) under a Creative Commons Attribution License. Abstract Biosimilar medicines expand the biotherapeutic market and improve….

Biosimilars 98

Biosimilars FDA Licensing Licensing 98

Drug Channels

SEPTEMBER 13, 2022

By now, you have already read innumerable articles explaining what’s in the new Inflation Reduction Act of 2022 (IRA; P.L. I can only barely scratch the surface in this article, so feel free to share your own thoughts in the comments below or on social media.

Biosimilars 97

Biosimilars Pharmacy Hospitals Marketing 97

Agency IQ

SEPTEMBER 1, 2023

s MHRA unveiled details of its new International Recognition Procedure, which will allow the MHRA to rely on marketing authorizations by reference regulators from several countries for a wide range of products, including generics and those that received expedited review. Fill out the form to read the full article. from the E.U.

International 52

International Regulations Pharmaceuticals Production 52

Drug Channels

DECEMBER 12, 2022

By now, you have already read innumerable articles explaining what’s in the new Inflation Reduction Act of 2022 (IRA; P.L. I can only barely scratch the surface in this article, so feel free to share your own thoughts in the comments below or on social media.

Biosimilars 98

Biosimilars Pharmacy Hospitals Marketing 98

Drug Patent Watch

JANUARY 15, 2025

This article explores the limitations of Google Patents in this context and suggests alternative approaches. Business Strategists Business strategists use patent data to inform market entry strategies and competitive analysis. The shortcomings of Google Patents may lead to misinformed decisions due to incomplete market insights.

Drugs 59

Drugs Pharmaceuticals Engineering Research 59